At Icahn School of Medicine at Mount Sinai, I proposed research directions in pulmonary fibrosis and pulmonary hypertension. I designed and synthesized peptide inhibitors for in vivo applications, then purified and characterized them using LC-MS.
My work at Mount Sinai also includes treating primary and cancer cell lines and measuring protein expression, RNA levels, and cellular co-localization. I’ve used Western blotting, RNA-seq, qPCR, and fluorescence microscopy for these studies.
At Memorial Sloan Kettering Cancer Center, I coordinated research projects, publications, and grant proposals. I synthesized and characterized small molecules, peptides, and chemical cross-linking probes to identify molecular targets of histone methyl-transferases.
During my doctoral research at University of California Riverside, I designed and synthesized peptide libraries against oncogenic protein targets. I also optimized peptide properties through structural modifications and functionalization.
